10th Digital Public Health Conference (DPH 2025)

24–31 Jul 2025 | On-site - Vidamar Resort Hotel Madeira

Phragma Therapeutics (Thera Phragma)

phragmatx.comPatra, Greece
1 profile visit

About

Phragma Therapeutics Inc. and its Greek Subsidiary Thera Phragma IKE is a biotechnology company specializing in the research and development of innovative therapies to address diseases related to the function of biological protective barriers of vital organs, such as the brain, the eye, and the intestine. The company's leading program aims to restore the pathological function of the Blood-Brain Barrier (BBB) to treat Central Nervous System (CNS) conditions of high unmet medical need. The company is also developing a proprietary platform technology to enhance the permeability of therapeutic agents (such as gene, cell, and RNA therapies, as well as other macromolecules) into the CNS, improving their efficacy and targeted action in patients with brain disorders.

Social media

Research & Innovation

Horizon EuropeCollaborative Projects

Health & Life Sciences

Pharmaceuticals / Biotech

Representatives

Vice President, Head of Biology

Phragma Therapeutics (Thera Phragma)